Por: RTTNews Health January 29, 2023
As we move into the shortest month of the year, let's take a look at some of the regulatory news reported during January. Eisai/Biogen's Leqembi was granted accelerated approval by the FDA for the treatment of Alzheimer's disease on Jan.6. It is the second new drug meant to slow the progression of the disease after Aduhelm, which was approved in June 2021.The FDA issued a draft guidance on the proposed action levels for lead in... + full article
The Boston Globe USA Business January 21, 2023
It’s hard to overstate the Boston biotechnology industry’s astronomical growth, which has overflowed from its longtime stronghold of Kendall Square in Cambridge into the Fenway, Seaport, and surrounding suburbs. But by most financial measures, 2022 was a terrible, horrible,... + más
NFL Week 4: Across the league, teams have hit the ground running this year | The Boston Globe
Boston biotech internship program aims to increase diversity through expansion | The Boston Globe
Fox Business USA Business January 17, 2023
Rep. Darrell Issa, R-Calif., discusses Biden's classified documents debacle, the latest 'Twitter File' that highlights the pharmaceutical industry's role in vaccine content, the U.S. debt ceiling and China's economy. The drug industry is now divided... + más
‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year. | The Boston Globe
Politico USA Health December 30, 2022
The FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más
Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times
Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News
ABC News USA Health December 20, 2022
WASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press
Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10
WPLG Local 10 USA Politics December 20, 2022
WASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News
Associated Press USA Politics December 19, 2022
WASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Forbes USA Business December 06, 2022
syringe sticking out of raw chickengetty Even combining cell-cultured meat with plant-based ingredients will still prove impossible to compete with the real thing in the marketplace. Recently, the U.S. Food and Drug Administration its “no questions” letter in response to... + más
Small amounts of dairy may protect against Type 2 diabetes: Study | Newsweek
Beyond Meat COO reportedly attempts to consume human nose | The Verge
About iurex | Privacy Policy | Disclaimer |